Case Discussion Metastatic glucagonoma in a patient with MEN 1 20.11.1399

Rahele Rasooli, MD  Fatemeh Rahmani, MD  Farzad Hadaegh, MD

Prevention of Metabolic Disorders Research Center,  Research Institute for Endocrine Science,

Shahid Beheshti University of Medical Sciences.

Tehran,Feb 2021

1. What are the differential diagnosis of skin lesions in our patient?
2. What are the MEN 1 syndrome clues in our patient?
3. What are the best approaches in this case?
4. How is the prognosis of our patient?